21 C.F.R. § 211.89

Rejected components, drug product containers, and closures.

Last amended: 2016Year: 2026Length: 31 wordsOfficial source

Cite as 21 C.F.R. § 211.89 (2026)

Rejected components, drug product containers, and closures shall be identified and controlled under a quarantine system designed to prevent their use in manufacturing or processing operations for which they are unsuitable.
21 C.F.R. § 211.89: Rejected components, drug product containers, and closures. | Justis AI